AERIE PHARMACEUTICALS INC - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 9, 2017

Attached files

file filename
EX-10.19 - EXHIBIT 10.19 - AERIE PHARMACEUTICALS INCaeri12312016ex-1019.htm
10-K - 10-K - AERIE PHARMACEUTICALS INCaeri-1231201610xk.htm
EX-32.2 - EXHIBIT 32.2 - AERIE PHARMACEUTICALS INCaeri12312016ex-322.htm
EX-32.1 - EXHIBIT 32.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-321.htm
EX-31.2 - EXHIBIT 31.2 - AERIE PHARMACEUTICALS INCaeri12312016ex-312.htm
EX-31.1 - EXHIBIT 31.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-311.htm
EX-23.1 - EXHIBIT 23.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-231.htm
EX-10.18.1 - EXHIBIT 10.18.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-10181.htm
EX-10.17.1 - EXHIBIT 10.17.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-10171.htm
EX-10.16.1 - EXHIBIT 10.16.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-10161.htm
EX-10.21 - EXHIBIT 10.21 - AERIE PHARMACEUTICALS INCaeri12312016ex-1021.htm
EX-10.20 - EXHIBIT 10.20 - AERIE PHARMACEUTICALS INCaeri12312016ex-1020.htm
EX-4.1.1 - EXHIBIT 4.1.1 - AERIE PHARMACEUTICALS INCaeri12312016ex-411.htm


Exhibit 21.1

Subsidiaries of Aerie Pharmaceuticals, Inc.


 
Subsidiary
Jurisdiction of Incorporation / Formation
Aerie Ownership
1

Aerie Pharmaceuticals Limited
Cayman Islands
100
%
2

Aerie Pharmaceuticals Ireland Limited
Ireland
100
%
3

Aerie Distribution, Inc.
Delaware
100
%



AERIE PHARMACEUTICALS INC Reports